Trials
Search / Trial NCT06429683

Effectıveness of The Sexually Transmıtted Dıseases Educatıon Program for Adolescents

Launched by BAHAR NUR KANBUR · May 23, 2024

Apply for Trial

Trial Information

Current as of February 08, 2025

Completed

Keywords

Adolescent Sexually Transmitted Diseases Education

ClinConnect Summary

People in the 15-49 age group who are sexually active are the most likely to contract sexually transmitted diseases. The prevalence of STDs is higher in developing countries than in developed countries. These diseases are among the top 5 etiologic factors that cause loss of years of "healthy productive life" in developing countries. As in other countries, sexually transmitted diseases are of great importance in terms of complications and sequelae in Turkey

One out of 20 young people is infected with STDs every year. In our country, the age of sexual maturation has shifted earlier. In addit...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • At a Foundation University located within the borders of Istanbul Province 1.2.3. and 4th grade students
  • Exclusion Criteria:
  • • -

Trial Officials

Canan Örüklü

Principal Investigator

Trakya University

About Bahar Nur Kanbur

Bahar Nur Kanbur is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, the organization collaborates with leading researchers and institutions to design, implement, and manage clinical trials across various therapeutic areas. Bahar Nur Kanbur prioritizes patient safety and data integrity, ensuring that all trials adhere to regulatory guidelines while fostering a culture of transparency and collaboration. Through its initiatives, the sponsor aims to contribute significantly to the development of effective treatments, enhancing the quality of life for patients worldwide.

Locations

Istanbul, Avcılar, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0